Trial Profile
A Study to Evaluate the Efficacy and Safety of Onabotulinum toxin A in Patients with Long-term Spasticity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Spastic paralysis
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2015 New trial record
- 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.